Recent studies have demonstrated that TMPO antisense RNA 1 (TMPO-AS1) serves as a competing endogenous RNA to sponge microRNAs (miRNAs) in multiple carcinomas, including hepatocellular carcinoma, thyroid cancer, lung adenocarcinoma, and breast cancer (10–13). Here, TMPO-AS1 is linked to lung adenocarcinoma.